Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant

    NEXT STORY
    HIV Cure Program Patent Granted To American Gene Technologies
    PREV STORY
    Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors – Corrected Version
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inventiva publie ses résultats financiers et fait le point sur ses activités pour le 1er semestre 2018

    Inventiva publie ses résultats financiers et fait le point sur ses activités pour le 1er ...

    author_avatar
    NASDAQ Market News

    Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused

    author_avatar
    NASDAQ Market News

    TESARO Announces Presentation of Niraparib Data at the 2016 IGCS Biennial Meeting

    WALTHAM, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

    author_avatar
    NASDAQ Market News